(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-05-23 View latest technical analysis
10 day averaged volume of Array Biopharma is 8368597
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Thu May 2024 | 12.79 | 12.94 | 12.98 | 12.38 | 0.538 times |
| 22 Wed May 2024 | 12.98 | 11.01 | 13.04 | 11.00 | 1.858 times |
| 21 Tue May 2024 | 11.11 | 10.63 | 11.13 | 10.60 | 0.569 times |
| 20 Mon May 2024 | 10.74 | 10.92 | 11.00 | 10.60 | 0.479 times |
| 17 Fri May 2024 | 10.96 | 11.31 | 11.33 | 10.85 | 0.688 times |
| 16 Thu May 2024 | 11.34 | 12.19 | 12.35 | 11.16 | 1.153 times |
| 15 Wed May 2024 | 12.24 | 13.17 | 13.60 | 12.13 | 0.96 times |
| 14 Tue May 2024 | 12.62 | 13.13 | 13.50 | 12.36 | 0.61 times |
| 13 Mon May 2024 | 12.66 | 12.98 | 13.26 | 12.64 | 0.638 times |
| 10 Fri May 2024 | 12.76 | 14.85 | 14.85 | 12.52 | 1.802 times |
My analysis of stock is bullish for shortterm, and stock might move up till 13.2 or till 14.2. Use a stoploss of 12.43 and if this stock hits its stoploss, then it can fall down till 11.63
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 10.60 |
| Downside Target | 10.82 |
| Downside Target | 11.08 |
| Downside Target | 11.38 |
| Downside Target | 12.07 |
| Downside Target | 12.52 |
| Upside Target | 12.81 |
| Upside Target | 13.60 |
| Upside Target | 13.98 |
| Upside Target | 14.85 |
| Upside Target | 15.12 |
| Upside Target | 15.35 |
| Upside Target | 16.22 |
| Upside Target | 17.76 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 11.25 |
| Downside Intraday Target | 9.7 |
| Upside Intraday Target | 13.69 |
| Upside Intraday Target | 14.58 |
| Downside Intraday Target | 12.14 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Thu May 2024 | 12.79 | 10.92 | 13.04 | 10.60 | 0.851 times |
| 17 Fri May 2024 | 10.96 | 12.98 | 13.60 | 10.85 | 0.844 times |
| 10 Fri May 2024 | 12.76 | 13.56 | 14.85 | 12.21 | 1.585 times |
| 03 Fri May 2024 | 13.46 | 12.56 | 13.98 | 12.07 | 1.028 times |
| 26 Fri Apr 2024 | 12.40 | 11.33 | 13.03 | 11.08 | 0.706 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Thu May 2024 | 12.79 | 12.38 | 14.85 | 10.60 | 1.066 times |
| 30 Tue Apr 2024 | 12.34 | 15.02 | 15.12 | 10.82 | 0.982 times |
| 28 Thu Mar 2024 | 14.91 | 13.68 | 15.35 | 11.38 | 0.868 times |
| 29 Thu Feb 2024 | 13.64 | 14.12 | 16.22 | 12.81 | 1.109 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.22 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 12.22 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.